NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$0.19
-0.06 (-24.61%)
▼
5d:
-35.81%
30d:
-76.85%
90d:
-84.56%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NIVF is down 35.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NIVF is down 35.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9422.62
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5850.70
100.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $0.19, which is considered slightly low relative to its 30-day fair value range of $0.10 to $0.65.
Technical Outlook: Technically, NIVF is in a downtrend. Immediate support is located at $0.07, while resistance sits at $0.36. Short-term momentum is weak, with the stock down 24.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $508.32 (+269709.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NIVF is in a downtrend. Immediate support is located at $0.07, while resistance sits at $0.36. Short-term momentum is weak, with the stock down 24.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $508.32 (+269709.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.10 -
$0.65
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-24.6%)
- BULLISH: Trading 269709.0% below Wall St target ($508.32)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.10 -
$0.65
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.07
Resistance Level
$0.36
Current Trend
Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Wall Street Target
$508.32
(+269709.0%)
Revenue Growth (YoY)
-4.7%
Profit Margin
24.2%
Share & Embed Analysis
Last updated: October 22, 2026 8:47 AM ET
Data refreshes hourly during market hours. Next update: 9:47 AM
Data refreshes hourly during market hours. Next update: 9:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 60 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 42 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 59 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 56 HOLD |
